Innate Pharma S.A. (LON:0EVI)
London · Delayed Price · Currency is GBP · Price in EUR 1.809
+0.075 (4.33%)
At close: Sep 15, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of 143.50 million as of September 16, 2025. Its market cap has decreased by -0.49% in one year.
Market Cap
143.50M
Enterprise Value
100.30M
Revenue
16.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.81
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 143.50M, an increase of 26,948.96%. That is a compound annual growth rate of 34.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 143.50M | 8.50% |
| Dec 31, 2024 | 132.26M | -27.85% |
| Dec 29, 2023 | 183.31M | -21.67% |
| Dec 30, 2022 | 234.02M | -20.77% |
| Dec 31, 2021 | 295.36M | 20.59% |
| Dec 31, 2020 | 244.93M | -38.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.00B |
| HSBC Holdings | 174.75B |
| Shell | 153.13B |
| Unilever | 114.20B |
| Rolls-Royce Holdings | 96.19B |
| British American Tobacco p.l.c. | 90.16B |
| Rio Tinto Group | 79.05B |
| BP p.l.c. | 64.73B |